2024 Partners

Alloy Therapeutics Logo

Expertise Partner

Alloy Therapeutics

Keyway TCR Discovery is a proprietary, integrated, end-to-end service for generating highly-specific therapeutically-optimized TCR mimic leads.  From immunizing our industry-leading ATX-Gx mice with high-quality protein-HLA complexes, to pairing in vitro and AI/ML capabilities for broad developability and specificity screening, to state-of-art engineering and bespoke functional screening capabilities, Keyway TCR Discovery creates leads you can develop with confidence.



Alithea Logo

Exhibition Partners

Alithea Biotechnology GmbH

Alithea Biotechnology GmbH (GER) is providing cutting-edge HLA peptidomics technologies for target discovery, validation and off-target toxicity profiling since 2019. Alithea has a web-accessible quantitative HLA peptide database, HLA-Compass, allowing to navigate peptide presentation in health and cancer. Proprietary HLA peptide binding predictors and strong experience in the quantification of HLA ligands together with most sensitive timsToF Ultra-powered mass spectrometry equipment facilitate high quality and sensitivity. Proteogenomics capabilities and an in-house repository of HLA typed tissue samples facilitate rapid validation of hypotheses for TCR/TCRm drug discovery. Alithea happily supports you in solving RnD challenges from target discovery to IND submission.


OmniAb Logo


At the heart of the OmniAb platform is the Biological Intelligence™ including OmniRat®, OmniChicken® and OmniMouse® that have been genetically modified to generate antibodies with human sequences. OmniFlic® (transgenic rat) and OmniClic® (transgenic chicken) address industry needs for bispecific antibody applications, and OmniTaur™ features unique structural attributes of cow antibodies for complex targets. OmnidAb ™ is an in vivo platform for single domain antibodies based upon a human VH scaffold. These proprietary technologies are joined with OmniDeep™, which is a suite of in silico tools. Additionally, an established core competency focused on ion channels and transporters further differentiates OmniAb’s technology.